Barrington Research Reaffirms Outperform Rating for OPKO Health (NASDAQ:OPK)
Barrington Research reiterated their outperform rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a research report released on Friday morning, Benzinga reports. Barrington Research currently has a $2.25 price objective on the biotechnology company’s stock. A number of other brokerages also recently commented on OPK. HC Wainwright reissued a buy rating and […]
More Stories
Greenland Lawmakers Approve US, Denmark Security Deal
By Jill McLaughlin Greenland lawmakers unanimously approved a security agreement Nov. 3 with the United States and Denmark that will...
The World Looks Upside Down…But It Isn’t
By Louis Navellier The world seems to have been turned upside down, and we are suddenly all living in “Opposite...
US Oil Prices Fall More Than 7 Percent on Iran Peace Talks
By Andrew Moran Crude oil prices fell sharply to start the trading week on hopes of peace talks with Iran....
Appeals Court Allows Trump Admin Effort Targeting Noncitizen Voting
By Zachary Stieber A federal appeals court on Nov. 3 reinstated a decision that stays a restraining order that had...
US Manufacturing Expands for 10th Straight Month Amid High Input Costs
By Bill Pan U.S. manufacturing activity strengthened in October as new orders increased, although raw materials became more expensive and...
America Votes: What to Expect
By Lawrence Wilson Democrats appear poised to win control of the House and possibly the Senate on Nov. 3 as...